Summary of Significant Accounting Policies (Tables)

12 Months Ended

Mar. 02, 2013

Summary of Significant Accounting Policies

Schedule of revenues

	Year Ended
	March 2, 2013 (52 Weeks)		March 3, 2012 (53 Weeks)		February 26, 2011 (52 Weeks)
Pharmacy sales	$	17,083,811	$	17,725,645	$	17,036,027
Front end sales		8,200,022		8,293,643		8,081,576
Other revenue		108,430		101,934		97,304
	$	25,392,263	$	26,121,222	$	25,214,907

Schedule of principal classes of products

The Company's principal classes of products in fiscal 2013 were the following:

Product Class	Percentage of Sales
Prescription drugs		67.6	%
Over-the-counter medications and personal care		9.9	%
Health and beauty aids		5.2	%
General merchandise and other		17.3	%